Characterizing the profile of obese patients who are metabolically healthy - PubMed (original) (raw)
Review
doi: 10.1038/ijo.2010.216. Epub 2010 Oct 26.
Affiliations
- PMID: 20975726
- DOI: 10.1038/ijo.2010.216
Review
Characterizing the profile of obese patients who are metabolically healthy
V Primeau et al. Int J Obes (Lond). 2011 Jul.
Abstract
The presence of obesity-related metabolic disturbances varies widely among obese individuals. Accordingly, a unique subset of obese individuals has been described in the medical literature, which seems to be protected or more resistant to the development of metabolic abnormalities associated with obesity. These individuals, now known as 'metabolically healthy but obese' (MHO), despite having excessive body fatness, display a favorable metabolic profile characterized by high levels of insulin sensitivity, no hypertension as well as a favorable lipid, inflammation, hormonal, liver enzyme and immune profile. However, recent studies have indicated that this healthier metabolic profile may not translate into a lower risk for mortality. Mechanisms that could explain the favorable metabolic profile of MHO individuals are poorly understood. However, preliminary evidence suggests that differences in visceral fat accumulation, birth weight, adipose cell size and gene expression-encoding markers of adipose cell differentiation may favor the development of the MHO phenotype. Despite the uncertainty regarding the exact degree of protection related to the MHO status, identification of underlying factors and mechanisms associated with this phenotype will eventually be invaluable in helping us understand factors that predispose, delay or protect obese individuals from metabolic disturbances. Collectively, a greater understanding of the MHO individual has important implications for therapeutic decision making, the characterization of subjects in research protocols and medical education.
Similar articles
- Metabolic and body composition factors in subgroups of obesity: what do we know?
Karelis AD, St-Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman ET. Karelis AD, et al. J Clin Endocrinol Metab. 2004 Jun;89(6):2569-75. doi: 10.1210/jc.2004-0165. J Clin Endocrinol Metab. 2004. PMID: 15181025 Review. - Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women.
Shin MJ, Hyun YJ, Kim OY, Kim JY, Jang Y, Lee JH. Shin MJ, et al. Int J Obes (Lond). 2006 Oct;30(10):1529-34. doi: 10.1038/sj.ijo.0803304. Epub 2006 Mar 21. Int J Obes (Lond). 2006. PMID: 16552406 - Metabolically healthy but obese individuals: relationship with hepatic enzymes.
Messier V, Karelis AD, Robillard ME, Bellefeuille P, Brochu M, Lavoie JM, Rabasa-Lhoret R. Messier V, et al. Metabolism. 2010 Jan;59(1):20-4. doi: 10.1016/j.metabol.2009.06.020. Epub 2009 Aug 25. Metabolism. 2010. PMID: 19709695 - Are there persons who are obese, but metabolically healthy?
Sims EA. Sims EA. Metabolism. 2001 Dec;50(12):1499-504. doi: 10.1053/meta.2001.27213. Metabolism. 2001. PMID: 11735101 Review. - The distinction of metabolically 'healthy' from 'unhealthy' obese individuals.
Blüher M. Blüher M. Curr Opin Lipidol. 2010 Feb;21(1):38-43. doi: 10.1097/MOL.0b013e3283346ccc. Curr Opin Lipidol. 2010. PMID: 19915462 Review.
Cited by
- Effect of metabolically healthy obesity on the development of arterial stiffness: a prospective cohort study.
Yuan Y, Mu JJ, Chu C, Zheng WL, Wang Y, Hu JW, Ma Q, Yan Y, Liao YY, Chen C. Yuan Y, et al. Nutr Metab (Lond). 2020 Jul 2;17:50. doi: 10.1186/s12986-020-00474-8. eCollection 2020. Nutr Metab (Lond). 2020. PMID: 32625239 Free PMC article. - Dietary total antioxidant capacity in relation to metabolic health status in overweight and obese adolescents.
Mohammadi S, Lotfi K, Mirzaei S, Asadi A, Akhlaghi M, Saneei P. Mohammadi S, et al. Nutr J. 2022 Aug 30;21(1):54. doi: 10.1186/s12937-022-00806-9. Nutr J. 2022. PMID: 36038871 Free PMC article. - Metabolic phenotypes of obesity: frequency, correlates and change over time in a cohort of postmenopausal women.
Kabat GC, Wu WY, Bea JW, Chen C, Qi L, Stefanick ML, Chlebowski RT, Lane DS, Wactawski-Wende J, Wassertheil-Smoller S, Rohan TE. Kabat GC, et al. Int J Obes (Lond). 2017 Jan;41(1):170-177. doi: 10.1038/ijo.2016.179. Epub 2016 Oct 17. Int J Obes (Lond). 2017. PMID: 27748744 Clinical Trial. - Metabolically Healthy Obesity and the Development of Nonalcoholic Fatty Liver Disease.
Chang Y, Jung HS, Cho J, Zhang Y, Yun KE, Lazo M, Pastor-Barriuso R, Ahn J, Kim CW, Rampal S, Cainzos-Achirica M, Zhao D, Chung EC, Shin H, Guallar E, Ryu S. Chang Y, et al. Am J Gastroenterol. 2016 Aug;111(8):1133-40. doi: 10.1038/ajg.2016.178. Epub 2016 May 17. Am J Gastroenterol. 2016. PMID: 27185080 - Impact of Self-Rated Health on Progression to a Metabolically Unhealthy Phenotype in Metabolically Healthy Obese and Non-Obese Individuals.
Kim MH, Chang Y, Jung HS, Shin H, Ryu S. Kim MH, et al. J Clin Med. 2019 Jan 1;8(1):34. doi: 10.3390/jcm8010034. J Clin Med. 2019. PMID: 30609650 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical